Skip to main content

Table 1 Relevant patient characteristics according to study group

From: Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study

Variables

Unmatched group

Matched group

All patients

(n = 1,723)

non-PMX-HP

(n = 1,201)

PMX-HP

(n = 522)

SD

P value

All patients

(n = 524)

non-PMX-HP

(n = 262)

PMX-HP

(n = 262)

SD

P value

Age, years

69.7 (13.8)

69.5 (14.0)

70.0 (13.1)

0.036

0.502

69.9 (13.1)

70.3 (13.4)

69.4 (12.8)

0.070

0.422

Male, n (%)

1019 (59.1)

705 (58.7)

314 (60.2)

0.030

0.574

304 (58.0)

150 (57.3)

154 (58.8)

0.031

0.723

Body weight, kg

56.6 (14.1)

56.6 (14.5)

56.6 (13.4)

0.007

0.903

56.5 (14.6)

56.0 (14.4)

57.0 (14.8)

0.064

0.465

Emergency center ICU, n (%)

729 (42.3)

486 (40.5)

243 (46.6)

0.123

0.019

239 (45.6)

121 (46.2)

118 (45.0)

0.023

0.793

Admission route to the ICU, n (%)

 Emergency department

735 (42.7)

543 (45.2)

192 (36.8)

0.172

0.000

215 (41.0)

109 (41.6)

106 (40.5)

0.023

0.790

 Other hospital

423 (24.6)

287 (23.9)

136 (26.1)

0.050

0.339

121 (23.1)

62 (23.7)

59 (22.5)

0.027

0.756

 Hospital ward

565 (32.8)

371 (30.9)

194 (37.2)

0.133

0.011

188 (35.9)

91 (34.7)

97 (37.0)

0.048

0.585

ICU policy, n (%)

 Open ICU

549 (31.9)

387 (32.2)

162 (31.0)

0.026

0.628

160 (30.5)

74 (28.2)

86 (32.8)

0.100

0.255

 Closed ICU

897 (52.1)

637 (53.0)

260 (49.8)

0.065

0.217

281 (53.6)

147 (56.1)

134 (51.1)

0.100

0.255

 Others

277 (16.1)

177 (14.7)

100 (19.2)

0.118

0.022

83 (15.8)

41 (15.6)

42 (16.0)

0.011

0.905

Number of ICU beds, number

12 (8–18)

12 (10–19)

10 (7–12)

0.429

<0.001

10.5 (8–16)

12 (8–15)

10 (7–16)

0.041

0.361

Pre-existing organ dysfunction, n (%)

 Liver insufficiency

83 (4.8)

49 (4.1)

34 (6.5)

0.109

0.032

30 (5.7)

12 (4.6)

18 (6.9)

0.099

0.262

 Chronic respiratory disorder

66 (3.8)

46 (3.8)

20 (3.8)

0.000

1.000

18 (3.4)

6 (2.3)

12 (4.6)

0.126

0.158

 Chronic heart failure

99 (5.7)

68 (5.7)

31 (5.9)

0.012

0.821

29 (5.5)

13 (5.0)

16 (6.1)

0.050

0.567

 Chronic hemodialysis

149 (8.6)

99 (8.2)

50 (9.6)

0.047

0.365

53 (10.1)

25 (9.5)

28 (10.7)

0.038

0.664

 Immunocompromised

299 (17.4)

218 (18.2)

81 (15.5)

0.070

0.185

83 (15.8)

43 (16.4)

40 (15.3)

0.031

0.720

 None

1,108 (64.3)

773 (64.4)

335 (64.2)

0.004

0.941

338 (64.5)

177 (67.6)

161 (61.5)

0.128

0.145

Severity

 APACHE II score

25.4 (8.9)

25.2 (8.9)

25.9 (8.9)

0.083

0.115

25.2 (9.2)

25.5 (8.9)

25.0 (9.5)

0.060

0.493

 SOFA score

11.5 (3.5)

11.2 (3.5)

12.0 (3.5)

0.246

<0.001

11.6 (3.4)

11.7 (3.4)

11.5 (3.4)

0.067

0.442

 SIRS positivea, n (%)

1,654 (96.0)

1151 (95.8)

503 (96.4)

0.027

0.611

499 (95.2)

253 (96.6)

246 (93.9)

0.126

0.157

 JAAM DIC positiveb, n (%)

1,092 (63.4)

723 (60.2)

369 (70.7)

0.222

<0.001

345 (65.8)

176 (67.2)

169 (64.5)

0.056

0.519

  1. Data are presented as mean (standard deviation), median (first quartile to third quartile), or number (percentage)
  2. aSIRS criteria ≥2
  3. bJAAM DIC score ≥4
  4. APACHE Acute Physiology and Chronic Health Evaluation, DIC disseminated intravascular coagulation, ICU intensive care unit, JAAM Japanese Association for Acute Medicine, PMX-HP polymyxin B hemoperfusion, SD standardized difference, SIRS systemic inflammatory response syndrome, SOFA Sequential Organ Failure Assessment